As of November, around one in eight adults in the US say they are currently taking a GLP-1 drug, whether for weight loss or another chronic condition. That is a remarkable adoption curve for a class of medicines that, until recently, sat largely inside diabetes care. It also explains why big pharma is moving fast,aaa

Agriculture is entering a decade in which incremental improvement will no longer be enough. Climate volatility, soil depletion, input price shocks, and tightening regulation are converging at the same time as global demand for nutritious, affordable food continues to rise. Against that backdrop, AgriTech is moving from promise to necessity. The question is no longeraaa

A Wealth of Ideas, But Few Unicorns British universities are world-renowned for pioneering research and spawning numerous spinout companies. From cybersecurity firm Darktrace to chip designer Arm, some of tech’s biggest names have emerged from UK academia. Indeed, the UK counts over 1,300 active university spinouts and has funneled billions into these ventures. Yet theaaa

Join the Innovation Forum & Shape the Future of Deep-Tech Innovation The Innovation Forum is delighted to announce the recruitment of a new cohort of branch leads for 2026! Please click here to apply. Are you passionate about deep-tech innovation, startups, and venture capital? As a branch lead, you’ll play a key role in drivingaaa

Tickets for our latest Healthcare 2.0 event, exploring the potential of cell and gene therapies, are available HERE. Over the last thirty years, the field of gene therapy has not only persisted but also achieved significant advancements, providing lasting treatments for an increasingly varied range of diseases. Currently, active clinical trials are addressing a spectrum ofaaa

Tickets for our latest Healthcare 2.0 event, exploring the potential of cell and gene therapies, are available HERE.   The role of cell therapy in heart treatment Cell-based therapy is a cutting-edge approach for treating heart problems, backed by over ten years of careful studies on cells and how they work. After completing initial safetyaaa

Imagine a world where healthcare is streamlined, optimised, and efficient thanks to the power of artificial intelligence. A world where a trip to the doctor’s office is hassle-free and appointments are available at a time that suits you. A world where diagnosis and treatment start as early as possible to give everyone the best possibleaaa

Narges Sheikhansari: Tell us about your team. What are your backgrounds and what is your founding story? Tanay Bhatt: At this stage of pre-expansion, we have a small team consisting of Professor Colin Jamora, Ms. Shreyaa, and myself. I did my PhD under Prof. Colin’s guidance, on the topics of wound-healing, antimicrobial resistance (AMR), and skin associatedaaa

This is an extract of our conversation with Eleanor, Craig and Franck from   VRS Recruitment. If you’re interested in the full interview, you can check it out here. Tatana: What do you think is the unique advantage of VRS? Craig: Recruitment agencies generally have quite a bad reputation. I think what makes us different isaaa

The Innovation Forum is excited to announce a strategic partnership with Discovery Park, a leading UK science park based in Kent, UK. This will help to elevate start-ups in the life sciences industry and open up networks between innovators and the wider science community. Located in the East of England’s life sciences cluster, with closeaaa